Improving access to immunotherapy in low- and middle-income countries

Ann Oncol. 2022 Apr;33(4):360-361. doi: 10.1016/j.annonc.2022.01.003. Epub 2022 Jan 13.

Authors

A Patel¹, D A Goldstein², I F Tannock³

Affiliations

¹ Department of Medicine, Oncology Centre, Indian Naval Hospital Ship, Asvini, Colaba, Mumbai, India.
² Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Optimal Cancer Care Alliance, Ann Arbor, USA.
³ Division of Medical Oncology, Princess Margaret Cancer Centre and University of Toronto, Toronto, Canada; Optimal Cancer Care Alliance, Ann Arbor, USA. Electronic address: ian.tannock@uhn.ca.

PMID: 35033637
DOI: 10.1016/j.annonc.2022.01.003

No abstract available

Publication types

Editorial

MeSH terms

Developing Countries*
Health Services Accessibility
Humans
Immunotherapy
Income*